Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic DifferentiationMaría E. Figueroa, Ari Melnick, Chao Lü et al.|Cancer Cell|2010Cited by 2.7k
Discontinuation Syndrome With JAK2 Selective Agents: Case Presentation and Mechanistic InsightsShivani Handa, Alan H. Shih|JCO Precision Oncology|2024Cited by 5